Paper36765737
Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer.
Liu J and 12 others. Cancers (Basel), 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. Papers, record 36765737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References185
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33884102 | Key drug-targeting genes in pancreatic ductal adenocarcinoma. | Genes Cancer | 2021 | https://conductscience.org/library/papers/33884102 | PubMed |
| 2 | 33160014 | Organoid model: A new hope for pancreatic cancer treatment? | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/33160014 | PubMed |
| 3 | 35352061 | Translational advances in pancreatic ductal adenocarcinoma therapy. | Nat Cancer | 2022 | https://conductscience.org/library/papers/35352061 | PubMed |
| 4 | 20981101 | The patterns and dynamics of genomic instability in metastatic pancreatic cancer. | Nature | 2010 | https://conductscience.org/library/papers/20981101 | PubMed |
| 5 | 11824803 | Malignant endocrine tumor of the pancreas associated with von Recklinghausen's disease. | J Gastroenterol | 2002 | https://conductscience.org/library/papers/11824803 | PubMed |
| 6 | 32250617 | Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer. | J Med Chem | 2020 | https://conductscience.org/library/papers/32250617 | PubMed |
| 7 | 25356972 | BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. | Genet Med | 2015 | https://conductscience.org/library/papers/25356972 | PubMed |
| 8 | 27496084 | Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. | Cancer | 2016 | https://conductscience.org/library/papers/27496084 | PubMed |
| 9 | 34572943 | Determinants of Homologous Recombination Deficiency in Pancreatic Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34572943 | PubMed |
| 10 | 23099806 | The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. | Br J Cancer | 2012 | https://conductscience.org/library/papers/23099806 | PubMed |
| 11 | 32147593 | Burden of Pancreatic Cancer: From Epidemiology to Practice. | Clin Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/32147593 | PubMed |
| 12 | 27400681 | GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27400681 | PubMed |
| 13 | 31605106 | Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion. | Ann Oncol | 2019 | https://conductscience.org/library/papers/31605106 | PubMed |
| 14 | 14508401 | Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. | Am J Surg Pathol | 2003 | https://conductscience.org/library/papers/14508401 | PubMed |
| 15 | 23673020 | Pancreatic cancer genomics: insights and opportunities for clinical translation. | Genome Med | 2013 | https://conductscience.org/library/papers/23673020 | PubMed |
| 16 | 15238885 | Epidemiology of pancreatic cancer. | Minerva Chir | 2004 | https://conductscience.org/library/papers/15238885 | PubMed |
| 17 | 19826425 | Familial association of pancreatic cancer with other malignancies in Swedish families. | Br J Cancer | 2009 | https://conductscience.org/library/papers/19826425 | PubMed |
| 18 | 33357065 | Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33357065 | PubMed |
| 19 | 29909163 | Update on multiple endocrine neoplasia Type 1 and 2. | Presse Med | 2018 | https://conductscience.org/library/papers/29909163 | PubMed |
| 20 | 32179180 | High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome. | J Thorac Oncol | 2020 | https://conductscience.org/library/papers/32179180 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877528 | Strategy for early diagnosis of pancreatic cancer. | Front Gastroenterol (Lausanne) | 2026 | https://conductscience.org/library/papers/42877528 | PubMed |
| 42461827 | Impact of Hypertrophy-Oriented Resistance Training on Muscle Mass and Quality of Life in Patients with Unresectable Pancreatic Cancer (HY-PANC): Study Protocol for a Randomized Controlled Trial. | Curr Protoc | 2026 | https://conductscience.org/library/papers/42461827 | PubMed |
| 41204213 | TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from Karachi, pakistan: a retrospective cohort study. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41204213 | PubMed |
| 40236698 | Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E. | Front Immunol | 2025 | https://conductscience.org/library/papers/40236698 | PubMed |
| 39906083 | Causal Exposures in Pancreatic Cancer Incidence: Insights From Mendelian Randomization Studies. | JGH Open | 2025 | https://conductscience.org/library/papers/39906083 | PubMed |
| 39334944 | Synergistic Inhibition of Pancreatic Cancer Cell Growth and Migration by Gemcitabine and Withaferin A. | Biomolecules | 2024 | https://conductscience.org/library/papers/39334944 | PubMed |
| 39138394 | Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements. | Drug Deliv | 2024 | https://conductscience.org/library/papers/39138394 | PubMed |
| 38542378 | A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542378 | PubMed |
| 38223763 | Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors. | PeerJ | 2024 | https://conductscience.org/library/papers/38223763 | PubMed |
| 37371705 | Therapeutic Approaches in Pancreatic Cancer: Recent Updates. | Biomedicines | 2023 | https://conductscience.org/library/papers/37371705 | PubMed |
Genes65
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36765737
GET https://conductscience.org/api/papers/v1/36765737/references?page=2